The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Intervening with Urinary Tract Infections Using Anti-Adhesives Based on the Crystal Structure of the FimH–Oligomannose-3 Complex
Open accessAbstract
BACKGROUND: Escherichia coli strains adhere to the normally sterile human uroepithelium using type 1 pili, that are long, hairy surface organelles exposing a mannose-binding FimH adhesin at the tip. A small percentage of adhered bacteria can successfully invade bladder cells, presumably via pathways mediated by the high-mannosylated uroplakin-Ia and alpha3beta1 integrins found throughout the uroepithelium. Invaded bacteria replicate and mature into dense, biofilm-like inclusions in preparation of fluxing and of infection of neighbouring cells, being the major cause of the troublesome recurrent urinary tract infections. METHODOLOGY/PRINCIPAL FINDINGS: We demonstrate that alpha-D-mannose based inhibitors of FimH not only block bacterial adhesion on uroepithelial cells but also antagonize invasion and biofilm formation. Heptyl alpha-D-mannose prevents binding of type 1-piliated E. coli to the human bladder cell line 5637 and reduces both adhesion and invasion of the UTI89 cystitis isolate instilled in mouse bladder via catheterization. Heptyl alpha-D-mannose also specifically inhibited biofilm formation at micromolar concentrations. The structural basis of the great inhibitory potential of alkyl and aryl alpha-D-mannosides was elucidated in the crystal structure of the FimH receptor-binding domain in complex with oligomannose-3. FimH interacts with Man alpha1,3Man beta1,4GlcNAc beta1,4GlcNAc in an extended binding site. The interactions along the alpha1,3 glycosidic bond and the first beta1,4 linkage to the chitobiose unit are conserved with those of FimH with butyl alpha-D-mannose. The strong stacking of the central mannose with the aromatic ring of Tyr48 is congruent with the high affinity found for synthetic inhibitors in which this mannose is substituted for by an aromatic group. CONCLUSIONS/SIGNIFICANCE: The potential of ligand-based design of antagonists of urinary tract infections is ruled by the structural mimicry of natural epitopes and extends into blocking of bacterial invasion, intracellular growth and capacity to fluxing and of recurrence of the infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Research works printed but not linked: 69
- H De Greve, 2007, Combining sites of bacterial fimbriae., Curr Opin Struct Biol, 17, 506, 10.1016/j.sbi.2007.06.011 · DOI
- G Zhou, 2001, Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding., J Cell Sci, 114, 4095, 10.1242/jcs.114.22.4095 · DOI · Paper page
- JD Schilling, 2003, Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance, to uropathogenic Escherichia coli., Proc Natl Acad Sci USA, 100, 4203, 10.1073/pnas.0736473100 · DOI · Paper page
- C Svanborg, 2006, Uropathogenic Escherichia coli as a model of host-parasite interaction., Curr Opin Microbiol, 9, 33, 10.1016/j.mib.2005.12.012 · DOI
- MA Mulvey, 1998, Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli., Science, 282, 1494, 10.1126/science.282.5393.1494 · DOI · Paper page
- JJ Martinez, 2000, Type 1 pilus-mediated bacterial invasion of bladder epithelial cells., EMBO J, 19, 2803, 10.1093/emboj/19.12.2803 · DOI · Paper page
- MA Mulvey, 2000, Bad bugs and beleaguered bladders: Interplay between uropathogenic Escherichia coli and innate host defenses., Proc Natl Acad Sci U S A, 97, 8829, 10.1073/pnas.97.16.8829 · DOI · Paper page
- IU Mysorekar, 2006, Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract., Proc Natl Acad Sci U S A, 103, 14170, 10.1073/pnas.0602136103 · DOI · Paper page
- GG Anderson, 2003, Intracellular bacterial biofilm-like pods in urinary tract infections., Science, 301, 105, 10.1126/science.1084550 · DOI · Paper page
- SS Justice, 2006, Maturation of intracellular Escherichia coli communities requires SurA., Infect Immun, 74, 4793, 10.1128/IAI.00355-06 · doi:10.1128/iai.00355-06
- SS Justice, 2006, Filamentation by Escherichia coli subverts innate defenses during urinary tract infection., Proc Natl Acad Sci U S A, 103, 19884, 10.1073/pnas.0606329104 · DOI · Paper page
- MA Mulvey, 2001, Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection., Infect Immun, 69, 4572, 10.1128/IAI.69.7.4572-4579.2001 · DOI · Paper page
- JD Schilling, 2002, Recent advances into the pathogenesis of recurrent urinary tract infections: the bladder as a reservoir for uropathogenic Escherichia coli., Internatl J Antimicrob Ag, 19, 457, 10.1016/S0924-8579(02)00098-5 · DOI
- SS Justice, 2004, Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis., Proc Natl Acad Sci U S A, 101, 1333, 10.1073/pnas.0308125100 · DOI · Paper page
- CK Garofalo, 2007, Escherichia coli from urine of female patients with urinary tract infections is competent for intracellular bacterial community formation., Infect Immun, 75, 52, 10.1128/IAI.01123-06 · DOI · Paper page
- KJ Wright, 2007, Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili., Cell Microbiol, 9, 2230, 10.1111/j.1462-5822.2007.00952.x · DOI · Paper page
- BL Bishop, 2007, Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells., Nat Med, 13, 625, 10.1038/nm1572 · DOI · Paper page
- G Apodaca, 2004, The uroepithelium: not just a passive barrier., Traffic, 5, 117, 10.1046/j.1600-0854.2003.00156.x · DOI · Paper page
- DS Eto, 2007, Flushing bacteria out of the bladder., Nat Med, 13, 531, 10.1038/nm0507-531 · doi:10.1038/nm0507-531
- DS Eto, 2006, Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli., Cell Microbiol, 8, 704, 10.1111/j.1462-5822.2006.00691.x · DOI
- S Langermann, 2000, Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli., J Infect Dis, 181, 774, 10.1086/315258 · DOI · Paper page
- N Sharon, 2006, Carbohydrates as future anti-adhesion drugs for infectious diseases., Biochim Biophys Acta, 1760, 527, 10.1016/j.bbagen.2005.12.008 · DOI · Paper page
- N Firon, 1983, Carbohydrate specificity of the surface lectins of Escherichia coli, Klebsiella pneumoniae and Salmonella typhimurium., Carbohydr Res, 120, 235, 10.1016/0008-6215(83)88019-7 · DOI · Paper page
- JR Neeser, 1986, Oligomannoside-type glycopeptides inhibiting adhesion of Escherichia coli strains mediated by type 1 pili: preparation of potent inhibitors from plant glycoproteins., Infect Immun, 52, 428, 10.1128/IAI.52.2.428-436.1986 · DOI
- N Sharon, 1987, Bacterial Lectins, cell-cell recognition and infectious disease., FEBS Lett, 217, 145, 10.1016/0014-5793(87)80654-3 · DOI · Paper page
- J Bouckaert, 2006, The affinity of the FimH fimbrial adhesin is receptor-driven and quasi-independent of Escherichia coli pathotypes., Mol Microbiol, 61, 1556, 10.1111/j.1365-2958.2006.05352.x · DOI
- EV Sokurenko, 1997, Diversity of the Escherichia coli type 1 fimbrial lectin. Differential binding to mannosides and uroepithelial cells., J Biol Chem, 272, 17880, 10.1074/jbc.272.28.17880 · DOI · Paper page
- MJ Duncan, 2005, The distinct binding specificities exhibited by enterobacterial type 1 fimbriae are determined by their fimbrial shafts., J Biol Chem, 280, 37707, 10.1074/jbc.M501249200 · doi:10.1074/jbc.m501249200
- P Aprikian, 2007, Interdomain interaction in the FimH adhesin of Escherichia coli regulates the affinity to mannose., J Biol Chem, 282, 23437, 10.1074/jbc.M702037200 · doi:10.1074/jbc.m702037200
- WE Thomas, 2002, Bacterial adhesion to target cells enhanced by shear force., Cell, 109, 913, 10.1016/S0092-8674(02)00796-1 · DOI · Paper page
- LM Nilsson, 2006, Catch bond-mediated adhesion without a shear threshold-Trimannose versus monomannose interactions with the FimH adhesin of Escherichia coli., J Biol Chem, 281, 16656, 10.1074/jbc.M511496200 · doi:10.1074/jbc.m511496200
- J Pak, 2001, Tamm-Horsfall protein binds to type 1 fimbriated Escherichia coli and prevents Escherichia coli from binding to uroplakin Ia and Ib receptors., J Biol Chem, 276, 9924, 10.1074/jbc.M008610200 · DOI · Paper page
- DS Eto, 2007, Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli., PLoS Pathog, 3, e100, 10.1371/journal.ppat.0030100 · DOI · Paper page
- G Min, 2002, Localization of uroplakin Ia, the urothelial receptor for bacterial adhesin FimH, on the six inner domains of the 16 nm urothelial plaque particle., J Mol Biol, 317, 697, 10.1006/jmbi.2002.5442 · DOI
- FX Liang, 2001, Organization of uroplakin subunits: transmembrane topology, pair formation and plaque composition., Biochem J, 355, 13, 10.1042/bj3550013 · doi:10.1042/bj3550013
- F Berditchevski, 2007, Tetraspanins as regulators of protein trafficking., Traffic, 8, 89, 10.1111/j.1600-0854.2006.00515.x · DOI · Paper page
- B Xie, 2006, Distinct glycan structures of uroplakins Ia and Ib: Structural basis for the selective binding of FimH adhesin to uroplakin Ia4., J Biol Chem, 281, 14644, 10.1074/jbc.M600877200 · DOI
- A Litynska, 2002, The structure of the oligosaccharides of alpha3beta1 integrin from human ureter epithelium (HCV29) cell line., Acta Biochim Pol, 49, 491, 10.18388/abp.2002_3808 · doi:10.18388/abp.2002_3808
- F Foulquier, 2004, Endoplasmic reticulum-associated degradation of glycoproteins bearing Man5GlcNAc2 and Man9GlcNAc2 species in the MI8-5 CHO cell line., Eur J Biochem, 271, 398, 10.1046/j.1432-1033.2003.03938.x · DOI
- IJ Rosenstein, 1988, New type of adhesive specificity revealed by oligosaccharide probes in Escherichia coli from patients with urinary tract infection., Lancet, 2, 1327, 10.1016/S0140-6736(88)90868-9 · DOI
- F Serafini-Cessi, 2005, N-Glycans carried by Tamm-Horsfall glycoprotein have a crucial role in the defense against urinary tract diseases., Glycoconjugate J, 22, 383, 10.1007/s10719-005-2142-z · DOI
- B Foxman, 2003, Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs., Dis Mon, 49, 53, 10.1067/mda.2003.7 · doi:10.1067/mda.2003.7 · Paper page
- SE Geerlings, 2002, Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells-More in diabetic women than in control subjects., Diabetes Care, 25, 1405, 10.2337/diacare.25.8.1405 · DOI
- SE Geerlings, 2002, Pathogenesis of bacteriuria in women with diabetes mellitus., Internatl J Antimicrob Ag, 19, 539, 10.1016/S0924-8579(02)00090-0 · DOI
- NE Norden, 1973, Mannose-containing trisaccharide isolated from urines of 3 patients with mannosidosis., J Biol Chem, 248, 6210, 10.1016/S0021-9258(19)43529-1 · doi:10.1016/s0021-9258(19)43529-1
- M Rijavec, 2006, High prevalence of multidrug resistance and random distribution of mobile genetic elements among uropathogenic Escherichia coli (UPEC) of the four major phylogenetic groups., Curr Microbiol, 53, 158, 10.1007/s00284-005-0501-4 · DOI
- J Bouckaert, 2005, Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin., Mol Microbiol, 55, 441, 10.1111/j.1365-2958.2004.04415.x · DOI · Paper page
- V Warin, 1979, The crystal and molecular structure of O-α-d-mannopyranosyl-(1-3)-O-β- d-mannopyranosyl-(1-4)-2-acetamido-2-deoxy-α-d-glucopyranose., Carbohydrate Res, 76, 11, 10.1016/0008-6215(79)80002-6 · doi:10.1016/0008-6215(79)80002-6
- MR Wormald, 2002, Conformational studies of oligosaccharides and glycopeptides: complementarity of NMR, X-ray crystallography, and molecular modelling., Chem Rev, 102, 371, 10.1021/cr990368i · DOI · Paper page
- E Krissinel, 2007, Inference of macromolecular assemblies from crystalline state., J Mol Biol, 372, 774, 10.1016/j.jmb.2007.05.022 · DOI · Paper page
- D Choudhury, 1999, X-ray structure of the FimC-FimH chaperone-adhesin complex from uropathogenic Escherichia coli., Science, 285, 1061, 10.1126/science.285.5430.1061 · DOI · Paper page
- C-S Hung, 2002, Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection., Mol Microbiol, 44, 903, 10.1046/j.1365-2958.2002.02915.x · DOI · Paper page
- BN Anderson, Weak rolling adhesion enhances bacterial surface colonization., J Bacteriol, 189, 1794, 10.1128/JB.00899-06 · DOI
- M Aronson, 1979, Prevention of colonization of the urinary-tract by blocking bacterial adherence with methyl-alpha-D-mannopyranoside., Israel J Med Sci, 15, 88
- LM Nilsson, 2006, Elevated shear stress protects Escherichia coli cells adhering to surfaces via catch bonds from detachment by soluble inhibitors., Appl Environ Microbiol, 72, 3005, 10.1128/AEM.72.4.3005-3010.2006 · doi:10.1128/aem.72.4.3005-3010.2006
- D Cavallone, 2004, Variation of high mannose chains of Tamm-Horsfall glycoprotein confers differential binding to type 1-fimbriated Escherichia coli., J Biol Chem, 279, 216, 10.1074/jbc.M308821200 · DOI
- PE Orndorff, 2004, Immunoglobulin-mediated agglutination of and biofilm formation by Escherichia coli K-12 require the type 1 pilus fiber., Infect Immun, 72, 1929, 10.1128/IAI.72.4.1929-1938.2004 · DOI
- J Valle, 2006, Broad-spectrum biofilm inhibition by a secreted bacterial polysaccharide., Proc Natl Acad Sci U S A, 103, 12558, 10.1073/pnas.0605399103 · DOI · Paper page
- GJ Kleywegt, 1996, Phi/psi-chology: Ramachandran revisited., Structure, 4, 1395, 10.1016/S0969-2126(96)00147-5 · DOI · Paper page
- M Touaibia, 2007, Mannosylated G(0) dendrimers with nanomolar affinities to Escherichia coli FimH., ChemMedChem, 2, 1190, 10.1002/cmdc.200700063 · doi:10.1002/cmdc.200700063
- Z Otwinowski, 1997, Processing of X-ray diffraction data collected in oscillation mode., Methods Enzymol, 276, 307, 10.1016/S0076-6879(97)76066-X · DOI · Paper page
- A Vagin, 1997, MOLREP: An automated program for molecular replacement., J Appl Crystallogr, 1022, 10.1107/S0021889897006766 · DOI · Paper page
- AT Brunger, 1998, Crystallography & NMR system: A new software suite for macromolecular structure determination., Acta Crystallogr D Biol Crystallogr, 54, 905, 10.1107/S0907444998003254 · DOI · Paper page
- GN Murshudov, 1997, Refinement of macromolecular structures by the maximum-likelihood method., Acta Crystallogr D Biol Crystallogr, 53, 240, 10.1107/S0907444996012255 · DOI · Paper page
- SC Lovell, 2003, Structure validation by Calpha geometry: phi, psi and Cbeta deviation., Proteins, 50, 437, 10.1002/prot.10286 · DOI · Paper page
- EJ Dodson, 1997, Collaborative computational project, number 4: Providing programs for protein crystallography., Methods Enzymol, 277, 620, 10.1016/S0076-6879(97)77034-4 · DOI · Paper page
- IK McDonald, 1994, Satisfying hydrogen bonding potential in proteins., J Mol Biol, 238, 777, 10.1006/jmbi.1994.1334 · DOI · Paper page
- IC Blomfield, 1991, Type 1 fimbriae mutants of Escherichia coli K12: characterization of recognized afimbriate strains and construction of new fim deletion mutants., Mol Microbiol, 5, 1439, 10.1111/j.1365-2958.1991.tb00790.x · DOI · Paper page
- FC Minion, 1989, The genetic determinant of adhesive function in type 1 fimbriae of Escherichia coli is distinct from the gene encoding the fimbrial subunit., J Bacteriol, 165, 1033, 10.1128/jb.165.3.1033-1036.1986 · doi:10.1128/jb.165.3.1033-1036.1986
Cited by
Recent Advances in Understanding Enteric Pathogenic Escherichia coli
Croxen, M. A., Law, R. J., Scholz, R., Keeney, K. M., Wlodarska, M., & Finlay, B. B. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00022-13 · Cited by 1,569
Uncomplicated Urinary Tract Infection
Hooton, T. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmcp1104429 · Cited by 885
From carbohydrate leads to glycomimetic drugs
Ernst, B., & Magnani, J. L. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2852 · Cited by 820
Bacterial Adhesins in Host-Microbe Interactions
Kline, K. A., Fälker, S., Dahlberg, S., Normark, S., & Henriques-Normark, B. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.05.011 · Cited by 630
Glycomimetics versus Multivalent Glycoconjugates for the Design of High Affinity Lectin Ligands
Cecioni, S., Imberty, A., & Vidal, S. (2015) · Chemical Reviews · doi:10.1021/cr500303t · Cited by 544
Metadata
- Authors
- Wellens, A., Garofalo, C., Nguyen, H., Van Gerven, N., Slättegård, R., Hernalsteens, J.-P., Wyns, L., Oscarson, S., De Greve, H., Hultgren, S., & Bouckaert, J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-04-30
- Volume
- 3
- Issue
- 4
- Pages
- e2040
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2114538173
- Cited by
- 249
- References
- 1
- FWCI
- 10.73
- Type
- journal article
- Language
- en
- Update notices
- correction (2008-06-09)
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intervening with Urinary Tract Infections Using Anti-Adhesives Based on the Crystal Structure of the FimH–Oligomannose-3 Complex. https://app.cochat.ai/papers/10.1371/journal.pone.0002040
- The paper
- Wellens, A., Garofalo, C., Nguyen, H., Van Gerven, N., Slättegård, R., Hernalsteens, J.-P., Wyns, L., Oscarson, S., De Greve, H., Hultgren, S., & Bouckaert, J. (2008). Intervening with Urinary Tract Infections Using Anti-Adhesives Based on the Crystal Structure of the FimH–Oligomannose-3 Complex. PLoS ONE. https://doi.org/10.1371/journal.pone.0002040
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.